DrugInfoSys

Chondroitin Sulphate

Drug #1780

Chondroitin Sulphate is an acid mucopolysaccharide which is a constituent of most mammalian cartilaginous tissue. Chondroitin Sulphate is used in osteoporosis, osteoarthritis, ischemic heart disease and hyperlipidemias.

← Previous drugNext drug →

Primary Characteristics

It is of Natural origin and belongs to Acid Mucopolysaccharide.

Molecular Weight: 25000 · Solubility in Water: soluble · Non-proprietary name: Chondroitin Sulphate.

Molecular structure of Chondroitin Sulphate

Pharmacokinetics

Absorption: Chondroitin Sulphate has an oral bioavailability is 19.5% (±4.5%).

Advertisement

Indications

Chondroitin Sulphate is primarily indicated in conditions like Osteoarthritis, Osteoporosis.

Contraindications

Chondroitin Sulphate is contraindicated in conditions like Breast feeding, Prostate cancer.

Dosage

Chondroitin Sulphate's dosage details are as follows:

DoseSingle DoseFrequencyRouteInstructions
Adult Dosage
400 mg400 mgEvery 8hPOFor osteoarthiritis.
Paediatric Dosage (20kg)
No data.
Neonatal Dosage (3kg)
No data.

Drug Interactions

None recorded.

Side Effects

Chondroitin Sulphate is known to cause more or less tolerable side effects which are usually transient. These include Nausea.

Warnings / Precautions

People need to take some precautions prior to using chondroitin sulfate. Some men with prostate cancer may develop an increased risk that the disease may recur or spread if they use this supplement. Some men should avoid this supplement if they already have an increased risk of getting prostate cancer. The effects of chondroitin sulfate in pregnant women are not known and they should avoid this supplement. Breastfeeding women should also avoid this nutritional supplement. Asthma -- there is some concern that chondroitin may worsen asthma symptoms: use with caution.

Available Brands

Click on a strength to view available brands.

Multi-Ingredient Combinations

Caplet
400 mg
Caps
100 mg200 mg400 mg
Sachet
200 mg400 mg
Syrup
200 mg/5ml
Tabs
400 mg600 mg

Drug Classification

  1. 1.18.14 — Drugs affecting bone metabolism

Manufacturers